SCHEMBL4849196

SCHEMBL4849196

COc1cc(C=O)ccc1OCc1cn(-c2ccccn2)nc1C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.54
MAPT P10636 5/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
NPC1 O15118 3/20 0.54
RAB9A P51151 3/20 0.54
HTT P42858 1/20 0.54
FDPS P14324 1/20 0.46
NPSR1 Q6W5P4 3/20 0.46
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
TSHR P16473 1/20 0.42
HPGD P15428 3/20 0.42
CYP2C9 P11712 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
TTR P02766 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4033996 0.83 SMN1; SMN2 (0.52) ALDH1A1MAPTSMN1; SMN2NPC1RAB9A
SCHEMBL4852667 0.82 RAB9A (0.45) ALDH1A1MAPTSMN1; SMN2NPC1RAB9A
SCHEMBL4855344 0.80 KDM4E (0.39) ALDH1A1MAPTSMN1; SMN2NPC1RAB9A
SCHEMBL1224760 0.76 ALDH1A1 (0.62) ALDH1A1MAPTSMN1; SMN2NPC1RAB9A
SCHEMBL28648496 0.74 ALDH1A1 (0.74) ALDH1A1MAPTSMN1; SMN2NPC1RAB9A
SCHEMBL28668979 0.73 ALDH1A1 (0.78) ALDH1A1MAPTSMN1; SMN2NPC1RAB9A
SCHEMBL15474905 0.71 ALDH1A1 (0.61) ALDH1A1MAPTSMN1; SMN2NPC1RAB9A
SCHEMBL20455968 0.71 ALDH1A1 (0.58) ALDH1A1MAPTSMN1; SMN2NPC1RAB9A
SCHEMBL13220785 0.70 ALDH1A1 (0.72) ALDH1A1MAPTSMN1; SMN2NPC1RAB9A
SCHEMBL5096223 0.70 ALDH1A1 (0.72) ALDH1A1MAPTSMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7368578-B2 Five-membered heterocyclic compounds TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-05-06 US disclosed
US-20060135578-A1 Five-membered heterocyclic compounds TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-06-22 US disclosed
EP-1541564-A1 FIVE-MEMBERED HETEROCYCLIC COMPOUNDS Takeda Pharmaceutical Company Limited (JP) 2005-06-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135578-A1 Five-membered heterocyclic compounds GPR119, OR10J3, CYP11B1 ALDH1A1 821/4885MAPT 4700/4885SMN1; SMN2 4339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.